JP2008137944A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008137944A5 JP2008137944A5 JP2006325657A JP2006325657A JP2008137944A5 JP 2008137944 A5 JP2008137944 A5 JP 2008137944A5 JP 2006325657 A JP2006325657 A JP 2006325657A JP 2006325657 A JP2006325657 A JP 2006325657A JP 2008137944 A5 JP2008137944 A5 JP 2008137944A5
- Authority
- JP
- Japan
- Prior art keywords
- powder
- cosmetics
- cosmetic
- copolymer
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000843 powder Substances 0.000 claims description 93
- 239000002537 cosmetic Substances 0.000 claims description 61
- 229920001577 copolymer Polymers 0.000 claims description 20
- 239000002131 composite material Substances 0.000 claims description 19
- 229920000642 polymer Polymers 0.000 claims description 18
- 239000011248 coating agent Substances 0.000 claims description 17
- 238000000576 coating method Methods 0.000 claims description 17
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 16
- 229910044991 metal oxide Inorganic materials 0.000 claims description 10
- 150000004706 metal oxides Chemical class 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 9
- PNEYBMLMFCGWSK-UHFFFAOYSA-N AI2O3 Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 8
- 229910000460 iron oxide Inorganic materials 0.000 claims description 8
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000000377 silicon dioxide Substances 0.000 claims description 8
- 239000004408 titanium dioxide Substances 0.000 claims description 8
- XLOMVQKBTHCTTD-UHFFFAOYSA-N zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 8
- 239000000178 monomer Substances 0.000 claims description 7
- MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 claims description 6
- 239000000470 constituent Substances 0.000 claims description 6
- 239000004472 Lysine Substances 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000000539 amino acid group Chemical group 0.000 claims description 4
- 239000011787 zinc oxide Substances 0.000 claims description 4
- NJNWCIAPVGRBHO-UHFFFAOYSA-N 2-hydroxyethyl-dimethyl-[(oxo-$l^{5}-phosphanylidyne)methyl]azanium Chemical group OCC[N+](C)(C)C#P=O NJNWCIAPVGRBHO-UHFFFAOYSA-N 0.000 claims description 3
- YHHSONZFOIEMCP-UHFFFAOYSA-O Phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 claims description 3
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims description 3
- 229950004354 phosphorylcholine Drugs 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- 125000004432 carbon atoms Chemical group C* 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N β-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- -1 triiron tetroxide Chemical compound 0.000 description 31
- 239000000203 mixture Substances 0.000 description 20
- 238000009472 formulation Methods 0.000 description 18
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 14
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229920001296 polysiloxane Polymers 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 239000006096 absorbing agent Substances 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 229940015001 Glycerin Drugs 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 229960005150 glycerol Drugs 0.000 description 6
- 230000003287 optical Effects 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N Trimethylglycine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000010445 mica Substances 0.000 description 5
- 229910052618 mica group Inorganic materials 0.000 description 5
- 238000000465 moulding Methods 0.000 description 5
- 239000004166 Lanolin Substances 0.000 description 4
- 229940039717 Lanolin Drugs 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000004381 surface treatment Methods 0.000 description 4
- OXNIZHLAWKMVMX-UHFFFAOYSA-N Picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229940114148 picric acid Drugs 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N titanium Chemical group [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 229950002929 trinitrophenol Drugs 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L Barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N Behenic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- OXJGJKIURHREKH-UHFFFAOYSA-O CC(=C)C(=O)OCCP(=O)=C(O)C[N+](C)(C)C Chemical compound CC(=C)C(=O)OCCP(=O)=C(O)C[N+](C)(C)C OXJGJKIURHREKH-UHFFFAOYSA-O 0.000 description 2
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-Threitol Natural products OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- 229940009714 Erythritol Drugs 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N Erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 210000000245 Forearm Anatomy 0.000 description 2
- 229940049906 Glutamate Drugs 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N Lauric acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N Oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N Palmitic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000002612 dispersion media Substances 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- QUEDXNHFTDJVIY-WENCSYSZSA-N gamma-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@](CCC[C@@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-WENCSYSZSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N n-butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- KREXGRSOTUKPLX-UHFFFAOYSA-N octadecanoic acid;zinc Chemical compound [Zn].CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O KREXGRSOTUKPLX-UHFFFAOYSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- YPXOPAFVVHXQDP-ZZEZOPTASA-N (1Z)-1-[(2,4-dimethylphenyl)hydrazinylidene]naphthalen-2-one Chemical compound CC1=CC(C)=CC=C1N\N=C/1C2=CC=CC=C2C=CC\1=O YPXOPAFVVHXQDP-ZZEZOPTASA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol;(Z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- FQYPKQOQUNFBDP-QMMMGPOBSA-N (2S)-6-amino-2-(2-methylprop-2-enoylamino)hexanoic acid Chemical compound CC(=C)C(=O)N[C@H](C(O)=O)CCCCN FQYPKQOQUNFBDP-QMMMGPOBSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N 1-Tetradecanol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-M 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC([O-])=O XDOFQFKRPWOURC-UHFFFAOYSA-M 0.000 description 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2,2'-azo-bis-isobutyronitrile Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N 2,2-dimethylpropane-1,3-diol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- OZZQHCBFUVFZGT-UHFFFAOYSA-N 2-(2-hydroxypropanoyloxy)propanoic acid Chemical compound CC(O)C(=O)OC(C)C(O)=O OZZQHCBFUVFZGT-UHFFFAOYSA-N 0.000 description 1
- IYAZLDLPUNDVAG-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 IYAZLDLPUNDVAG-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N 2-Imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (Z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-hydroxypropyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N 2-methyl-2-propenoic acid methyl ester Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N 3-(2,3-dihydroxypropoxy)propane-1,2-diol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-Aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- PZZYQPZGQPZBDN-UHFFFAOYSA-N Aluminium silicate Chemical compound O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 description 1
- 229940063655 Aluminum stearate Drugs 0.000 description 1
- OZAIFHULBGXAKX-VAWYXSNFSA-N Azobisisobutyronitrile Chemical compound N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 229960000686 Benzalkonium Chloride Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N Benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- GLQBXSIPUULYOG-UHFFFAOYSA-M Bismuth oxychloride Chemical compound Cl[Bi]=O GLQBXSIPUULYOG-UHFFFAOYSA-M 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- XOJVVFBFDXDTEG-UHFFFAOYSA-N Bute hydrocarbon Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 1
- 229960003563 Calcium Carbonate Drugs 0.000 description 1
- 229940073532 Candelilla Wax Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N Cetyl alcohol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- LBFUKZWYPLNNJC-UHFFFAOYSA-N Cobalt(II,III) oxide Chemical compound [Co]=O.O=[Co]O[Co]=O LBFUKZWYPLNNJC-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-α-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 229940105990 DIGLYCERIN Drugs 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N Deoxyribose Chemical group OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N Dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N Dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- NOPFSRXAKWQILS-UHFFFAOYSA-N Docosanol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N Hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 241000748095 Hymenopappus filifolius Species 0.000 description 1
- AXISYYRBXTVTFY-UHFFFAOYSA-N Isopropyl myristate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)C AXISYYRBXTVTFY-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L Magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N Malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N Maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940023607 Myristic Acid Drugs 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- 229940117969 NEOPENTYL GLYCOL Drugs 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 229940116985 POTASSIUM LAURYL SULFATE Drugs 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 229940098695 Palmitic Acid Drugs 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229940055726 Pantothenic Acid Drugs 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229940066842 Petrolatum Drugs 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N Phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 229960005323 Phenoxyethanol Drugs 0.000 description 1
- 239000004698 Polyethylene (PE) Substances 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M Potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- MMXZSJMASHPLLR-UHFFFAOYSA-N Pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N Rhamnose Chemical group C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N Silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N Simethicone Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 210000003491 Skin Anatomy 0.000 description 1
- 229940005581 Sodium Lactate Drugs 0.000 description 1
- 229940045870 Sodium Palmitate Drugs 0.000 description 1
- 229940045920 Sodium Pyrrolidone Carboxylate Drugs 0.000 description 1
- NGSFWBMYFKHRBD-UHFFFAOYSA-M Sodium lactate Chemical compound [Na+].CC(O)C([O-])=O NGSFWBMYFKHRBD-UHFFFAOYSA-M 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M Sodium laurate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 Sodium laurate Drugs 0.000 description 1
- JNYAEWCLZODPBN-CTQIIAAMSA-N Sorbitan Chemical compound OCC(O)C1OCC(O)[C@@H]1O JNYAEWCLZODPBN-CTQIIAAMSA-N 0.000 description 1
- 229960005078 Sorbitan sesquioleate Drugs 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N Squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229960004274 Stearic acid Drugs 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N Stearyl alcohol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- 210000004243 Sweat Anatomy 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N THP Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- YXHBBEQKMVAJOH-GLCFPVLVSA-K Tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 YXHBBEQKMVAJOH-GLCFPVLVSA-K 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N TiO Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N Tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Tris Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N Undecylenic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- 229940045997 Vitamin A Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- RMRCNWBMXRMIRW-WYVZQNDMSA-L Vitamin B12 Chemical compound N([C@@H]([C@@]1(C)[C@@](C)(CC(N)=O)[C@H](CCC(N)=O)\C(N1[Co+]C#N)=C(/C)\C1=N\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NCC(C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO RMRCNWBMXRMIRW-WYVZQNDMSA-L 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229940046008 Vitamin D Drugs 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229940046009 Vitamin E Drugs 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N Xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 Xylitol Drugs 0.000 description 1
- NWGKJDSIEKMTRX-HSACVWGTSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] (E)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-HSACVWGTSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 229940087168 alpha Tocopherol Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- 229960001452 alpha-Tocopherol Acetate Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 125000000089 arabinosyl group Chemical group C1([C@@H](O)[C@H](O)[C@H](O)CO1)* 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 150000008316 benzisoxazoles Chemical class 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- SOGAXMICEFXMKE-UHFFFAOYSA-N butyl 2-methylprop-2-enoate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N butylene glycol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Chemical group 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229950008690 docosanoic acid Drugs 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 229950006877 dodecanoic acid Drugs 0.000 description 1
- CNNPNFVEEMWBBH-UHFFFAOYSA-N dodecyl(oxido)azanium Chemical compound CCCCCCCCCCCC[NH2]=O CNNPNFVEEMWBBH-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 230000001804 emulsifying Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting Effects 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- WUKXMJCZWYUIRZ-UHFFFAOYSA-N hexadecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(C)O WUKXMJCZWYUIRZ-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- LNCPIMCVTKXXOY-UHFFFAOYSA-N hexyl 2-methylprop-2-enoate Chemical compound CCCCCCOC(=O)C(C)=C LNCPIMCVTKXXOY-UHFFFAOYSA-N 0.000 description 1
- LNMQRPPRQDGUDR-UHFFFAOYSA-N hexyl prop-2-enoate Chemical compound CCCCCCOC(=O)C=C LNMQRPPRQDGUDR-UHFFFAOYSA-N 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 229940033355 lauric acid Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 239000011776 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000002609 media Substances 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000003020 moisturizing Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- HMZGPNHSPWNGEP-UHFFFAOYSA-N octadecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(C)=C HMZGPNHSPWNGEP-UHFFFAOYSA-N 0.000 description 1
- FSAJWMJJORKPKS-UHFFFAOYSA-N octadecyl prop-2-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C=C FSAJWMJJORKPKS-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- NZIDBRBFGPQCRY-UHFFFAOYSA-N octyl 2-methylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C(C)=C NZIDBRBFGPQCRY-UHFFFAOYSA-N 0.000 description 1
- 229940065472 octyl acrylate Drugs 0.000 description 1
- ANISOHQJBAQUQP-UHFFFAOYSA-N octyl prop-2-enoate Chemical compound CCCCCCCCOC(=O)C=C ANISOHQJBAQUQP-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N pantothenic acid Natural products OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000000379 polymerizing Effects 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 230000001376 precipitating Effects 0.000 description 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 description 1
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 description 1
- 229940095050 propylene Drugs 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N rac-1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000006104 solid solution Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229910001929 titanium oxide Inorganic materials 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 230000001052 transient Effects 0.000 description 1
- PDSVZUAJOIQXRK-UHFFFAOYSA-N trimethyl(octadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)C PDSVZUAJOIQXRK-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- XYLMUPLGERFSHI-UHFFFAOYSA-N α-Methylstyrene Chemical compound CC(=C)C1=CC=CC=C1 XYLMUPLGERFSHI-UHFFFAOYSA-N 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
Description
本発明は、化粧料用の粉体及びそれを含有する化粧もちを向上させた化粧料に関する。 The present invention relates to a powder for cosmetics and a cosmetic having improved makeup containing the powder.
油脂などを被覆した粉体を加圧成形した固形粉末化粧料は、簡単な化粧動作できれいな仕上がりが出来る利点を有しているため、ファンデーションなどとして広く使用されるようになってきている。その反面、当初は、粉体の吸油性による乾燥感、化粧崩れがしやすい等の欠点も存していた。乾燥感については、ハイドロジェンメチルポリシロキサン焼付などのシリコーン処理を粉体に施し、且つ、粉体自身を油性成分で被覆することにより乾燥感は顕著に軽減された(例えば、特許文献1を参照)。化粧崩れに関しては、シリコーンによる表面処理と、粘性の高い油脂の被覆による、化粧膜の密着性の向上により、改善されたが、実用上化粧直しは、乳化型のファンデーションなどと比較すると、頻繁に行わなければならないのが現状であった。即ち、疎水性を粉体に付与すること、或いは、粉体に油性物質で粘着性を付与することによっては解決できない化粧崩れの因子が存することが推察される。即ち、固形粉末化粧料に於いて、化粧持ちを更に改善する技術の開発が望まれていたと言える。 Solid powder cosmetics obtained by pressure-molding powders coated with fats and oils have an advantage that a beautiful finish can be achieved with a simple cosmetic operation, and thus have been widely used as foundations and the like. On the other hand, there were also disadvantages such as a dry feeling due to the oil-absorbing property of the powder and a tendency to break the makeup. Regarding dry feeling, the dry feeling was remarkably reduced by applying silicone treatment such as baking with hydrogenmethylpolysiloxane to the powder and coating the powder with an oil component ( see, for example, Patent Document 1). ). For the makeup, the surface treatment with silicone, by coating a highly viscous oil, by improving the adhesion of the decorative film has been improved, practically facelift, compared including the foundations of emulsifying, frequent It was the current situation that we had to. That is, to impart hydrophobicity to powders, or the powder in the oily substance by to impart tackiness it is presumed that resolution can such have of粧崩Re factors exists. That is, it can be said that the development of a technique for further improving the longevity of the makeup in the solid powder cosmetic is desired.
一方、板状粉体には、化粧仕上がりの上で種々の光学的効果を奏するものが多く、セリサイトであれば、自然なツヤ感を創出する作用を有するし、マイカであれば立体感をツヤ感によって付与できるし、チタンマイカであれば、パール光沢により、明るく立体的な印象を創出できる。その中でも注目されるのは、自然なカバー力を呈する化粧料用の粉体であるセリサイトなどの鱗片状の粉体の表面をシリカ、アルミナ、二酸化チタン、酸化鉄などの金属酸化物で被覆した複合粉体である(例えば、特許文献2、特許文献3、特許文献4を参照)。この様な複合化粉体を包含する板状粉体に於いては、前記のような表面処理による化粧持ち向上の試みは行いにくい。これはこの様な被覆によって粉体表面に形成される被覆層が、複合体の有している光学効果を著しく損なう場合が存したり、板状であるため、汗などの上を疎水化処理した粉体が滑って、移動したりするためである。従って、表面を処理することが出来ないこの様な粉体を化粧料が含有した場合、前記の表面処理による効果は著しく減じてしまうのが実状であった。この様な傾向は前記複合粉体に於いては特に著しい。この様な、複合粉体に於いて、光学効果を損なうことなく、化粧持ちを向上せしめる技術の開発が望まれていたと言える。 On the other hand, many plate-like powders have various optical effects in terms of cosmetic finish. If sericite is used, it has the effect of creating a natural luster, and if it is mica, it gives a three-dimensional effect. It can be given with a glossy feeling, and if it is titanium mica, it can create a bright and three-dimensional impression with pearl luster. Is being noted among them, the scaly surface of the powder, such as powder der ruse Risaito for cosmetics exhibiting natural covering power silica, alumina, titanium dioxide, a metal oxide such as iron oxide coated a composite powder (e.g., refer to Patent Document 2, Patent Document 3, Patent Document 4). In the plate-like powder including such a composite powder, it is difficult to try to improve the cosmetic durability by the surface treatment as described above. This is because the coating layer formed on the powder surface by such coating may significantly impair the optical effect of the composite, or it is plate-like, so the top of sweat etc. is hydrophobized. This is because the dried powder slides and moves. Therefore, in the case where the cosmetic contains such a powder whose surface cannot be treated, the effect of the surface treatment is remarkably reduced. Such a tendency is particularly remarkable in the composite powder. In such a composite powder, it can be said that development of a technique for improving the longevity of makeup without impairing the optical effect has been desired.
他方、粉体による乾燥感を抑制したり、粉体に保湿を付与する目的で、アクリル酸誘導体を構成モノマーとするポリマー乃至はコポリマーで粉体を被覆し、化粧料に含有させる技術は、既に知られている(例えば、特許文献5、特許文献6を参照)が、化粧持ちとの関係は全く知られていない。又、複合粉体をこの様なポリマー乃至はコポリマーで被覆する技術も全く知られていない。 On the other hand, for the purpose of suppressing the feeling of drying by the powder or imparting moisture retention to the powder, the technology of coating the powder with a polymer or copolymer having an acrylic acid derivative as a constituent monomer and including it in cosmetics has already been developed. that have known (e.g., Patent Document 5, refer to Patent Document 6), it is completely unknown relationship with makeup. Also, there is no known technique for coating the composite powder with such a polymer or copolymer.
本発明は、この様な状況下為されたものであり、板状の形状を有する複合粉体の化粧持ちを向上せしめる手段を提供することを課題とする。 The present invention has been made under such circumstances, and an object of the present invention is to provide a means for improving the cosmetic durability of a composite powder having a plate shape.
この様な状況に鑑みて、本発明者らは、板状の形状を有する複合粉体の化粧持ちを向上せしめる手段を求めて、鋭意研究努力を重ねた結果、特定の複合粉体の表面に後記一般式(1)に表されるアクリル酸誘導体を構成モノマーとするポリマー乃至はコポリマーを被覆することにより、この様な化粧持ちの向上が為しうることを見いだし、発明を完成させるに至った。即ち、本発明は、以下に示すとおりである。
(1)1)セリサイトの表面をシリカ、アルミナ、酸化鉄、二酸化チタン、酸化亜鉛、ジルコニアから選択される1種乃至は2種以上の金属酸化物で被覆した複合粉体を、2)次に示す一般式(1)に表されるアクリル酸誘導体を構成モノマーとするポリマー乃至はコポリマーで、更に被覆してなる化粧料用の粉体。
In view of such a situation, the present inventors have sought for means for improving the longevity of the composite powder having a plate-like shape, and as a result of earnest research efforts , It has been found that such a long-lasting improvement in makeup can be achieved by coating a polymer or copolymer having an acrylic acid derivative represented by the general formula (1) described below as a constituent monomer. . That is, the present invention is as follows.
(1) 1) A composite powder in which the surface of sericite is coated with one or more metal oxides selected from silica, alumina, iron oxide, titanium dioxide, zinc oxide and zirconia. A powder for cosmetics, which is further coated with a polymer or copolymer containing an acrylic acid derivative represented by the general formula (1) shown in FIG.
(但し、式中R 1 は水素原子又は炭素数1〜4のアルキル基を表し、R 2 は糖残基、アミノ酸残基又はホスホリルコリン残基を表し、nは0〜4の整数を表す。)
(In the formula, R 1 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, R 2 represents a sugar residue, an amino acid residue or a phosphorylcholine residue, and n represents an integer of 0 to 4).
(2)前記ポリマー乃至コポリマーは、ポリメタクリロイルオキシエチルホスホリルコリン、ポリメタクリロイルリジン、ポリメタクリロイルオキシエチルグルコース及びメタクリル酸ブチル・メタクリロイルオキシエチルホスホリルコリン共重合体から選択されるものであることを特徴とする、(1)に記載の化粧料用の粉体。
(3)前記ポリマー乃至はコポリマーの被覆量は、化粧料用の粉体の全質量に対して、0.1〜10質量%であることを特徴とする、(1)又は(2)の何れかに記載の化粧料用の粉体。
(4) (1)〜(3)の何れかに記載の化粧料用の粉体を含有してなる化粧料。
(5)固形粉末化粧料であることを特徴とする、(4)に記載の化粧料。
(2) the polymer to copolymer is characterized in that it is intended to be selected polymethacryloylacetones oxyethyl phosphorylcholine, polymethacryloylacetones Le lysine, from polymethacryloylacetones oxyethyl glucose and methacrylic acid butyl methacryloyloxyethyl phosphorylcholine copolymer, ( The powder for cosmetics as described in 1) .
(3) The coating amount of the polymer or copolymer is 0.1 to 10% by mass with respect to the total mass of the powder for cosmetics , either (1) or (2) Powder for cosmetics according to crab .
(4) A cosmetic comprising the cosmetic powder according to any one of (1) to ( 3) .
(5) The cosmetic according to (4) , which is a solid powder cosmetic.
本発明によれば、板状の形状を有する複合粉体の化粧持ちを向上せしめる手段を提供することができる。 ADVANTAGE OF THE INVENTION According to this invention, the means which can improve the cosmetic durability of the composite powder which has plate shape can be provided.
(1)本発明の粉体の基体となる板状の複合粉体
本発明の化粧料用の粉体は、板状粉体であるセリサイトを基体として、これに金属酸化物を被覆した複合粉体を、更に前記一般式(1)に表されるアクリル酸誘導体を構成モノマーとするポリマー乃至はコポリマーで被覆したものであることを特徴とする。前記金属酸化物としては、シリカ、アルミナ、二酸化チタン、酸化亜鉛、ジルコニア、ベンガラ、黄色酸化鉄乃至は四三酸化鉄などの酸化鉄が挙げられ、これらは独立した状態で被覆して
いても良いし、固溶体や焼結体のように複合化した形で被覆しても良い。又、この様な金属酸化物は唯一種であっても二種以上であっても良い。この様な粉体における質量比の構成は、基体となる板状粉体40〜90質量%に対して、金属酸化物が10〜60質量%であることが好ましく、基体となる板状粉体60〜80質量%に対して、金属酸化物が20〜40質量%であることがより好ましい。この様な複合粉体としては、チタンセリサイトと称せられる、セリサイト60〜90質量%に対して、残余の質量の二酸化チタンを被覆したもの、セリサイトが40〜80質量%、アルミナとシリカの質量の総和が0.1〜40質量%、他の金属酸化物が5〜20質量%である、触媒化成工業株式会社製の「カバーリーフAR20121M」(セリサイト60質量%、シリカ10質量%、アルミナ20質量%、二酸化チタン10質量%)、「ダーマリアルリーフN」(シリカ10質量%、酸化鉄10質量%、二酸化チタン5質量%被覆セリサイト)、「カットリーフAV」(アルミナ0.8質量%、二酸化チタン17.2質量%、ベンガラ1.6質量%でセリサイト78.4質量%を被覆し、更にステアリン酸亜鉛を2質量%被覆した粉体)等が好適に例示できる。これらは何れも市販されている。この様な構成を取らないものでも、常法に従って調製し、用いることも出来る。調製は、金属酸化物を構成する金属の可溶性塩を溶解させた水性媒体中に板状粉体であるセリサイトを分散させ、これにアルカリを徐々に加え、中和し、金属の水酸化物を析出せしめ、これを焼成することにより製造することが出来る。かかる粉体には更に表面処理を行うことも出来るが、好ましい表面処理としては、ステアリン酸亜鉛やステアリン酸アルミニウム等の脂肪酸金属石鹸の被覆処理、N−ステアロイルグルタミン酸アルミニウム等のN−アシルグルタミン酸塩の被覆処理などが例示できる。
(1) powder cosmetics of the powder substrate and comprising a plate-like composite powder present invention of the present invention, as a substrate sericite is a plate-like powder, and this coating the metal oxide composite The powder is further coated with a polymer or copolymer having an acrylic acid derivative represented by the general formula (1) as a constituent monomer. The metal oxide, shea silica, alumina, titanium dioxide, zinc oxide, zirconia, iron oxide, or yellow iron oxide include iron oxide such as triiron tetroxide, these are not covered by the independent state Alternatively, it may be coated in a composite form such as a solid solution or a sintered body. Such metal oxides may be a single species or two or more species. The composition of the mass ratio in such a powder is such that the metal oxide is preferably 10 to 60% by mass with respect to 40 to 90% by mass of the plate-like powder that becomes the base, and the plate-like powder that becomes the base The metal oxide is more preferably 20 to 40% by mass with respect to 60 to 80% by mass. As such composite powder, is called a titanium sericite, against sericite 60-90 wt%, those coated with titanium dioxide of the remaining mass, sericite 40 to 80 wt%, alumina “Coverleaf AR20121M” (catalyst 60% by mass, silica 10% by mass) manufactured by Catalyst Kasei Kogyo Co., Ltd., having a total mass of silica of 0.1 to 40% by mass and other metal oxides of 5 to 20% by mass. %, Alumina 20% by mass, titanium dioxide 10% by mass), “Derma Real Leaf N” (silica 10% by mass, iron oxide 10% by mass, titanium dioxide 5% by mass coated sericite), “Cut Leaf AV” (Alumina 0 8% by mass, 17.2% by mass of titanium dioxide, 1.6% by mass of Bengala, 78.4% by mass of sericite, and 2% by mass of zinc stearate) It can be suitably exemplified. These are all commercially available. Even those which do not have such a structure can be prepared and used according to a conventional method. In the preparation, sericite, which is a plate-like powder , is dispersed in an aqueous medium in which a soluble salt of a metal constituting a metal oxide is dissolved, and an alkali is gradually added to this to neutralize the metal hydroxide. It can be manufactured by precipitating and firing this. Such powder may be further subjected to surface treatment, but preferred surface treatments include coating treatment with fatty acid metal soap such as zinc stearate and aluminum stearate, and N-acyl glutamate such as aluminum N-stearoyl glutamate. A covering process etc. can be illustrated.
斯くして得られた複合粉体に、前記一般式(1)に表されるアクリル酸誘導体を構成モノマーとするポリマー乃至はコポリマーを被覆することにより、本発明の粉体は製造される。この様なポリマーについて、これを構成するモノマーには一般式(1)に表されるアクリル酸誘導体が構成モノマーとして含まれるが、前記一般式(1)において、R1は水素原子又は炭素数1〜4のアルキル基を表し、より好適にはメチル基を表す。R2は糖残基、アミノ酸残基又はホスホリルコリン残基を表し、該糖残基としては、グルコース残基、フルクトース残基、リボース残基、デオキシリボース残基、アラビノース残基、ガラクトース残基、ラムノース残基等が例示でき、特に好適には、グルコース残基である。前記アミノ酸残基としては、例えば、リジン残基、グリシン残基、アラニン残基、グルタミン残基、グルタミン酸残基などが好適に例示でき、特にリジン残基が好適に例示できる。又、nは0〜4の整数を表し、より好適には0又は2である。この様な一般式(1)に表されるアクリル酸誘導体としては、具体的には、例えば、メタクリロイルオキシエトチルグルコシルエーテル、メタクリロイルオキシエチルホスホリルコリン、メタクリロイルリジンなどが好適例示できる。又、コポリマーに於いて、かかる一般式(1)に表されるアクリル酸誘導体とともに重合に用いられるモノマーとしては、例えば、アクリル酸、メタクリル酸、アクリル酸メチル、アクリル酸エチル、アクリル酸プロピル、アクリル酸ブチル、アクリル酸ヘキシル、アクリル酸オクチル、アクリル酸ステアリルなどのアクリル酸アルキル、メタクリル酸メチル、メタクリル酸エチル、メタクリル酸プロピル、メタクリル酸ブチル、メタクリル酸ヘキシル、メタクリル酸オクチル、メタクリル酸ステアリルなどのメタクリル酸アルキル、酢酸ビニル、ビニルアルコール、スチレン、α−メチルスチレンなどが好適に例示できる。これらのモノマーを、例えば、アゾビスイソブチロニトリル等を触媒に、常法に従って重合することにより、前記ポリマー乃至はコポリマーは製造することが出来る。この様なポリマー乃至はコポリマーには既に市販されているものも存し、この様な市販品を購入して利用することも出来る。この様な市販品としては、例えば、日本油脂株式会社から販売されている「リピジュアHM」(ポリメタクリロイルオキシエチルホスホリルコリン)、「リピジュアPMB」(メタクリロイルオキシエチルホスホリルコリン・ブチルメタクリレートコポリマー)、日本精化株式会社から販売されている「p−GEMA」(ポリメタクリロイルオキシエトチルグルコシルエーテル)、岐阜シェラ
ック株式会社から販売されている「PMリジン」(ポリメタクリロイルリジン)等が好適に例示できる。
The powder of the present invention is produced by coating the composite powder thus obtained with a polymer or copolymer having an acrylic acid derivative represented by the general formula (1) as a constituent monomer. Regarding such a polymer, the monomer constituting the polymer includes an acrylic acid derivative represented by the general formula (1) as a constituent monomer. In the general formula (1), R1 is a hydrogen atom or a carbon number of 1 to 1. Represents an alkyl group of 4, more preferably a methyl group. R2 represents a sugar residue, an amino acid residue or a phosphorylcholine residue, which includes a glucose residue, a fructose residue, a ribose residue, a deoxyribose residue, an arabinose residue, a galactose residue, a rhamnose residue. Examples thereof include a group, and particularly preferably a glucose residue. As the amino acid residue, for example, a lysine residue, a glycine residue, an alanine residue, a glutamine residue, a glutamic acid residue and the like can be preferably exemplified, and a lysine residue can be particularly preferably exemplified. N represents an integer of 0 to 4, more preferably 0 or 2. Specific examples of the acrylic acid derivative represented by the general formula (1) include methacryloyloxyethyl glucosyl ether, methacryloyloxyethyl phosphorylcholine, methacryloyl lysine, and the like. In the copolymer, monomers used for polymerization together with the acrylic acid derivative represented by the general formula (1) include, for example, acrylic acid, methacrylic acid, methyl acrylate, ethyl acrylate, propyl acrylate, acrylic Methacrylates such as butyl acrylate, hexyl acrylate, octyl acrylate, stearyl acrylate, etc., alkyl acrylate, methyl methacrylate, ethyl methacrylate, propyl methacrylate, butyl methacrylate, hexyl methacrylate, octyl methacrylate, stearyl methacrylate, etc. Preferable examples include acid alkyl, vinyl acetate, vinyl alcohol, styrene, α-methylstyrene and the like. By polymerizing these monomers using, for example, azobisisobutyronitrile as a catalyst according to a conventional method, the polymer or copolymer can be produced. Some of these polymers or copolymers are already on the market, and such commercial products can be purchased and used. Examples of such commercially available products include “Lipidure HM” (polymethacryloyloxyethyl phosphorylcholine), “Lipidure PMB” (methacryloyloxyethyl phosphorylcholine / butyl methacrylate copolymer) sold by Nippon Oil & Fats Co., Ltd., Nippon Seika Co., Ltd. “P-GEMA” (polymethacryloyloxyethyl glucosyl ether) sold by the company, “PM lysine” (polymethacryloyl lysine) sold by Gifu Shellac Co., Ltd. and the like can be suitably exemplified.
前記複合粉体にこれらのポリマー乃至はコポリマーを被覆する方法は、常法に従って行えば良く、例えば、かかる基体となる複合粉体90〜99.9質量%に対し、ポリマー乃至はコポリマーが0.1〜10質量%になるように、溶媒乃至は分散媒にポリマー乃至はコポリマーを1〜10質量倍の可溶化乃至は分散させて、好ましくは20〜100℃で被覆し、所望により減圧条件で、溶媒除去することにより製造できる。この様な溶媒乃至は分散媒としては、水、エタノール、イソプロパノール及びブタノールから選択される1種乃至は2種以上が好適に例示できる。 The method for coating the composite powder with these polymers or copolymers may be carried out in accordance with a conventional method. For example, the polymer or copolymer is added in an amount of 0.8 to 99.9% by mass with respect to 90 to 99.9% by mass of the composite powder as the substrate. The polymer or copolymer is solubilized or dispersed 1 to 10 times by mass in a solvent or dispersion medium so as to be 1 to 10% by mass, preferably coated at 20 to 100 ° C., and optionally under reduced pressure conditions. It can be produced by removing the solvent. As such a solvent or dispersion medium, one or more selected from water, ethanol, isopropanol and butanol can be suitably exemplified.
斯くして得られた本発明の粉体は、基体となるセリサイトからなる複合粉体の自然なカバー力という光学効果を発揮しつつ、化粧持ちも著しく向上する。 The powder of the present invention obtained in this way exhibits the optical effect of the natural covering power of the composite powder composed of sericite as a base, and the cosmetic durability is remarkably improved.
(2)本発明の化粧料
本発明の化粧料は、前記本発明の化粧料用の粉体を含有することを特徴とする。本発明の化粧料としては、固形粉末化粧料が好ましい。本発明に言う固形粉末化粧料とは、粉体に所望により30質量%以下の油脂成分をコーティングし、これを固形に成形したもので、該成型手段としては、加圧成型などが好適に例示できる。本発明の化粧料に於いては、前記必須成分の化粧料用の粉体は、唯一種を含有することも出来るし、二種以上を組み合わせて含有することも出来る。本発明の化粧料における、必須成分である本発明の化粧料用粉体の含有量であるが、かかる粉体の光学効果が現れる量であれば特段の限定はないが、総量で、化粧料全量に対して、1〜60質量%が好ましく、より好ましくは10〜40質量%である。かかる量範囲に於いて、自然なカバー力の発現などの光学効果が化粧料に付与される。
(2) Cosmetics of this invention The cosmetics of this invention contain the powder for cosmetics of the said this invention, It is characterized by the above-mentioned. As the cosmetic of the present invention, a solid powder cosmetic is preferable. The solid powder cosmetic referred to in the present invention is obtained by coating powder with an oil / fat component of 30% by mass or less as desired, and molding the solid into a solid, and suitable examples of the molding means include pressure molding. it can. In the cosmetic of the present invention, the cosmetic powder as the essential component may contain only one species or a combination of two or more species. The content of the cosmetic powder of the present invention, which is an essential component in the cosmetic of the present invention, is not particularly limited as long as the optical effect of the powder appears, but the total amount of the cosmetic is not limited. 1-60 mass% is preferable with respect to the whole quantity, More preferably, it is 10-40 mass%. In such a quantity range, optical effects such as natural covering power of expression is applied to cosmetics.
本発明の皮膚外用剤においては、かかる成分以外に、通常粉体化粧料で使用される任意成分を含有することが出来る。この様な任意成分としては、例えば、マカデミアナッツ油、アボカド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類;流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類;オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類;セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール等;イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ−2−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−2−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類;ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン;オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン;アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類;脂肪酸セッケン(ラウリン酸ナトリウム、パルミチン酸ナトリウム等)、ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等
のアニオン界面活性剤類;塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類;イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、アシルメチルタウリン等の両性界面活性剤類;ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等)、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、POEソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等)、POEアルキルエーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類;ポリエチレングリコール、グリセリン、1,3−ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2−ペンタンジオール、2,4−ヘキサンジオール、1,2−ヘキサンジオール、1,2−オクタンジオール等の多価アルコール類;ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類;表面を処理されていても良い、マイカ、タルク、カオリン、合成雲母、炭酸カルシウム、炭酸マグネシウム、無水ケイ酸(シリカ)、酸化アルミニウム、硫酸バリウム等の粉体類、;表面を処理されていても良い、ベンガラ、黄酸化鉄、黒酸化鉄、酸化コバルト、群青、紺青、酸化チタン、酸化亜鉛の無機顔料類;表面を処理されていても良い、雲母チタン、魚燐箔、オキシ塩化ビスマス等のパール剤類;レーキ化されていても良い赤色202号、赤色228号、赤色226号、黄色4号、青色404号、黄色5号、赤色505号、赤色230号、赤色223号、橙色201号、赤色213号、黄色204号、黄色203号、青色1号、緑色201号、紫色201号、赤色204号等の有機色素類;ポリエチレン末、ポリメタクリル酸メチル、ナイロン粉末、オルガノポリシロキサンエラストマー等の有機粉体類;パラアミノ安息香酸系紫外線吸収剤;アントラニル酸系紫外線吸収剤;サリチル酸系紫外線吸収剤;桂皮酸系紫外線吸収剤;ベンゾフェノン系紫外線吸収剤;糖系紫外線吸収剤;2−(2’−ヒドロキシ−5’−t−オクチルフェニル)ベンゾトリアゾール、4−メトキシ−4’−t−ブチルジベンゾイルメタン等の紫外線吸収剤類;エタノール、イソプロパノール等の低級アルコール類;ビタミンA又はその誘導体、ビタミンB 6 塩酸塩、ビタミンB 6 トリパルミテート、ビタミンB 6 ジオクタノエート、ビタミンB 2 又はその誘導体、ビタミンB 12 、ビタミンB 15 又はその誘導体等のビタミンB類;α−トコフェロール、β−トコフェロール、γ−トコフェロール、ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類等;フェノキシエタノール等の抗菌剤などが好ましく例示できる。これらの成分を常法に従って処理することにより、本発明の化粧料は製造することが出来る。
The external preparation for skin of the present invention can contain, in addition to such components, optional components that are usually used in powder cosmetics. Examples of such optional components, e.g., macadamia nut oil, Abou transient oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, cured Oils such as coconut oil, hydrogenated oil, molasses, hydrogenated castor oil, beeswax, candelilla wax, carnauba wax, ibotarou, lanolin, reduced lanolin, hard lanolin, jojoba wax, liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin , Hydrocarbons such as petrolatum, microcrystalline wax; higher fatty acids such as oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid; cetyl alcohol, stearyl alcohol, isostearyl Higher alcohols such as alcohol, behenyl alcohol, octyldodecanol, myristyl alcohol, cetostearyl alcohol; cetyl isooctanoate, isopropyl myristate, hexyldecyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, malic acid Diisostearyl, di-2-ethylhexanoic acid ethylene glycol, dicaprate neopentyl glycol, di-2-heptylundecanoic acid glycerin, tri-2-ethylhexanoic acid glycerin, tri-2-ethylhexanoic acid trimethylolpropane, tri Synthetic ester oils such as trimethylolpropane isostearate and pentane erythritol tetra-2-ethylhexanoate; dimethylpolysiloxane, methylphenylpoly Linear polysiloxanes such as oxane and diphenylpolysiloxane; cyclic polysiloxanes such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and dodecamethylcyclohexanesiloxane; amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, Oil agents such as silicone oils such as modified polysiloxanes such as fluorine-modified polysiloxanes; Anionic surfactants such as fatty acid soap (sodium laurate, sodium palmitate, etc.), potassium lauryl sulfate, triethanolamine ether of alkyl sulfates; Cationic surfactants such as stearyltrimethylammonium, benzalkonium chloride, laurylamine oxide; imidazoline-based amphoteric surfactants (2-cocoyl-2-imida Zolinium hydroxide-1-carboxyethyloxy disodium salt, etc.), betaine surfactants (alkyl betaine, amide betaine, sulfobetaine, etc.), and amphoteric surfactants such as acylmethyltaurine; sorbitan fatty acid esters (sorbitan) Monostearate, sorbitan sesquioleate, etc.), glycerin fatty acids (eg, glyceryl monostearate), propylene glycol fatty acid esters (eg, propylene glycol monostearate), hardened castor oil derivatives, glycerin alkyl ethers, POE sorbitan fatty acid esters (POE sorbitan monooleate, polyoxyethylene sorbitan monostearate, etc.), POE sorbite fatty acid esters (POE-sorbitol monolaurate, etc.), POE glycerin fatty acid ester Tells (POE-glycerol monoisostearate, etc.), POE fatty acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2-octyldodecyl ether, etc.), POE alkylphenyl ethers (POE nonylphenyl) Ethers, etc.), Pluronic types, POE / POP alkyl ethers (POE / POP2-decyltetradecyl ether, etc.), Tetronics, POE castor oil / hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), Nonionic surfactants such as sucrose fatty acid ester and alkyl glucoside; polyethylene glycol, glycerin, 1,3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene Polyhydric alcohols such as recall, dipropylene glycol, diglycerin, isoprene glycol, 1,2-pentanediol, 2,4-hexanediol, 1,2-hexanediol, 1,2-octanediol; sodium pyrrolidonecarboxylate Moisturizing ingredients such as lactic acid and sodium lactate; powders such as mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, anhydrous silicic acid (silica), aluminum oxide, barium sulfate, etc. whose surface may be treated Body, the surface may be treated, inorganic pigments such as bengara, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine, bitumen, titanium oxide, zinc oxide; surface may be treated, mica Pearl agents such as titanium, fish phosphorus foil, bismuth oxychloride; red 202 which may be raked, red Color 228, Red 226, Yellow 4, Blue 404, Yellow 5, Red 505, Red 230, Red 223, Orange 201, Red 213, Yellow 204, Yellow 203, Blue 1 No., green 201, purple 201, red 204, etc .; organic powders such as polyethylene powder, polymethyl methacrylate, nylon powder, organopolysiloxane elastomer; para-aminobenzoic acid UV absorbers; anthranils Acid UV absorbers; salicylic acid UV absorbers ; cinnamic acid UV absorbers ; benzophenone UV absorbers; sugar UV absorbers; 2- (2′-hydroxy-5′-t-octylphenyl) benzotriazole; UV absorbers such as 4-methoxy-4′-t-butyldibenzoylmethane; lower alcohols such as ethanol and isopropanol Vitamin B such as vitamin A or a derivative thereof, vitamin B 6 hydrochloride, vitamin B 6 tripalmitate, vitamin B 6 dioctanoate, vitamin B 2 or a derivative thereof, vitamin B 12 , vitamin B 15 or a derivative thereof; Vitamin E such as α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E acetate, vitamin D, vitamin H, pantothenic acid, pantethine, pyrroloquinoline quinone and the like; antibacterial agents such as phenoxyethanol are preferred It can be illustrated. The cosmetic of the present invention can be produced by treating these components according to a conventional method.
以下に、本発明について、以下に実施例および参考例を挙げて、更に詳細説明を加えるが、本発明がかかる実施例にのみ限定されないことは言うまでもない。 Hereinafter, the present invention will be described in more detail with reference to examples and reference examples . Needless to say, the present invention is not limited to these examples.
<参考例1>
以下に示す処方に従って、化粧料用の粉体を製造した。即ち、ディスパーを用いて、200回転/分でイを攪拌しながら、これにロを徐々に加えた。全量が添加された後700
0回転/分の速度で10分分散し、これを真空脱泡した後、減圧下20℃で4日間乾燥させ、しかる後に0.7mmφ丸穴スクリーンを装着したパルベライザーで粉砕して、化粧料用の粉体1を得た。
<Reference Example 1>
According to the formulation shown below, was prepared the powder for reduction粧料. That is, using a disper, B was gradually added to this while stirring i at 200 rpm. 700 after all is added
0 rev / min speed and 10 minutes dispersion, after vacuum defoaming this dried 4 days in vacuo at 20 ° C., and pulverized in a pulverizer equipped with 0.7mmφ round hole screen Thereafter, reduction粧料Powder 1 was obtained.
<実施例1>
参考例1と同様に下記処方に従って製造し、本発明の化粧料用の粉体2を得た。
<Example 1>
Prepared according to the following formulation in the same manner as in Reference Example 1 to obtain a powder 2 for reduction粧料of the present invention.
<実施例2>
参考例1と同様に下記処方に従って製造し、本発明の化粧料用の粉体3を得た。
<Example 2>
Prepared according to the following formulation in the same manner as in Reference Example 1 to obtain a powder 3 for reduction粧料of the present invention.
<実施例3>
参考例1と同様に下記処方に従って製造し、本発明の化粧料用の粉体4を得た。
<Example 3>
Prepared according to the following formulation in the same manner as in Reference Example 1 to obtain a powder 4 for粧料of the present invention.
<実施例4>
参考例1と同様に下記処方に従って製造し、本発明の化粧料用の粉体5を得た。
<Example 4>
Prepared according to the following formulation in the same manner as in Reference Example 1 to obtain a powder 5 for reduction粧料of the present invention.
<実施例5>
参考例1と同様に下記処方に従って製造し、本発明の化粧料用の粉体6を得た。
<Example 5>
Prepared according to the following formulation in the same manner as in Reference Example 1 to obtain a powder 6 for reduction粧料of the present invention.
<実施例6>
参考例1と同様に下記処方に従って製造し、本発明の化粧料用の粉体7を得た。
<Example 6>
Prepared according to the following formulation in the same manner as in Reference Example 1 to obtain a powder 7 for reduction粧料of the present invention.
<実施例7>
参考例1と同様に下記処方に従って製造し、本発明の化粧料用の粉体8を得た。
<Example 7>
Prepared according to the following formulation in the same manner as in Reference Example 1 to obtain a powder 8 for reduction粧料of the present invention.
<実施例8>
参考例1と同様に下記処方に従って製造し、本発明の化粧料用の粉体9を得た。
<Example 8>
Prepared according to the following formulation in the same manner as in Reference Example 1 to obtain a powder 9 for reduction粧料of the present invention.
<実施例9>
参考例1と同様に下記処方に従って製造し、本発明の化粧料用の粉体10を得た。
<Example 9>
Prepared according to the following formulation in the same manner as in Reference Example 1 to obtain a powder 10 for reduction粧料of the present invention.
<実施例10>
参考例1と同様に下記処方に従って製造し、本発明の化粧料用の粉体11を得た。
<Example 10>
Prepared according to the following formulation in the same manner as in Reference Example 1 to obtain a powder 11 for reduction粧料of the present invention.
<実施例11>
参考例1と同様に下記処方に従って製造し、本発明の化粧料用の粉体12を得た。
<Example 11>
Prepared according to the following formulation in the same manner as in Reference Example 1 to obtain a powder 12 for reduction粧料of the present invention.
<実施例12>
参考例1と同様に下記処方に従って製造し、本発明の化粧料用の粉体13を得た。
<Example 12>
Prepared according to the following formulation in the same manner as in Reference Example 1 to obtain a powder 13 for reduction粧料of the present invention.
<実施例13>
参考例1と同様に下記処方に従って製造し、本発明の化粧料用の粉体14を得た。
<Example 13>
Prepared according to the following formulation in the same manner as in Reference Example 1 to obtain a powder 14 for reduction粧料of the present invention.
<参考例2>
参考例1と同様に、セリサイトに「リピジュアHM」を被覆して比較例1を得た。
<Reference Example 2 >
As in Reference Example 1 , Comparative Example 1 was obtained by coating sericite with “Lipidure HM”.
<参考例3>
参考例1と同様に、セリサイトに「リピジュアPMB」を被覆して比較例2を得た。
<Reference Example 3 >
As in Reference Example 1 , Comparative Example 2 was obtained by coating sericite with “Lipidure PMB”.
<参考例4>
参考例1と同様に、セリサイトに「p−GEMA」を被覆して比較例3を得た。
<Reference Example 4 >
As in Reference Example 1 , Comparative Example 3 was obtained by coating sericite with “p-GEMA”.
<参考例5>
参考例1と同様に、セリサイトに「PMリジン」を被覆して比較例4を得た。
<Reference Example 5 >
As in Reference Example 1 , Comparative Example 4 was obtained by coating sericite with “PM lysine”.
<実施例14>
下記に示す処方に従って、本発明の化粧料である、固形粉末化粧料を作製した。即ち、イの成分をヘンシェルミキサーで混合し、0.9mmφ丸穴スクリーンを装着したパルベライザーで粉砕し、ヘンシェルミキサーで再度混合しながらロの成分を噴霧し、コーティングして、1mmヘリングボーンスクリーンを装着したパルベライザーで粉砕し、金皿に充填し、加圧成型して参考の化粧料1と、化粧料2〜5を得た。同様の操作で、未処理の粉体を用いた比較例5〜9、比較例1の粉体に置換した比較例10も同様に作製した。これらについて、前腕内側部に2cm×4cmの部位を設け、部位の位置がわかるようにマーキングした後、検体40mgをウレタンチップを用いて塗布し、4時間通常の生活状態で過ごした後、それぞれの部位にピクリン酸の1%エタノール溶液を含浸させた直径2cmのパルプディスクを30秒置いて取り外し、速やかに前腕全体を温流水下、石鹸を用いて洗浄し、洗浄後10分静置し、部位以外の部分と、パルプディスクを置いた部分の色差(ΔE)をコニカミノルタ色彩色差計CR400で測定し、ピクリン酸の染着程度を調べた。この結果も表20に示す。これより、本発明の化粧料は、参考の化粧料や比較例の化粧料に比してピクリン酸の染着を抑制しており、この効果は本発明の化粧料用の粉体の化粧崩れをしにくくする作用によるものであることがわかる。
<Example 14>
A solid powder cosmetic, which is the cosmetic of the present invention, was prepared according to the formulation shown below. That is, the ingredients of A are mixed with a Henschel mixer, pulverized with a pulverizer equipped with a 0.9mmφ round hole screen, sprayed with the ingredients of B while being mixed again with a Henschel mixer, coated, and fitted with a 1mm herringbone screen. Trituration with the pulverizer, then filled in a metal dish, and cosmetics 1 reference to pressure molding to obtain a cosmetic 2-5. In a similar manner, Comparative Examples 5 to 9 using untreated powder and Comparative Example 10 substituted with the powder of Comparative Example 1 were also produced. About these, after providing a 2 cm × 4 cm site on the inner side of the forearm and marking so that the location of the site can be understood, 40 mg of the sample was applied using a urethane chip, and after spending 4 hours in a normal living state, Remove the 2 cm diameter pulp disc impregnated with 1% ethanolic solution of picric acid at the site for 30 seconds, quickly wash the entire forearm with soap under warm running water, and leave it for 10 minutes after washing. The color difference (ΔE) between the other part and the part where the pulp disk was placed was measured with a Konica Minolta color difference meter CR400, and the degree of dyeing of picric acid was examined. The results are also shown in Table 20. Thus, the cosmetic of the present invention suppresses the dyeing of picric acid compared to the reference cosmetic and the cosmetic of the comparative example, and this effect is caused by the cosmetic disintegration of the powder for the cosmetic of the present invention. It can be seen that this is due to the effect of making it difficult to perform.
<実施例15>
実施例14と同様に、下記の処方に従って、本発明の化粧料である、化粧料6〜8を作製し、同様に評価した。同様に粉体として比較例2を用いた比較例11も製造し、評価した。結果を表22に示す。実施例14と同様の結果が得られた。
<Example 15>
In the same manner as in Example 14 , cosmetics 6 to 8, which are the cosmetics of the present invention, were prepared according to the following formulation and evaluated in the same manner. Similarly, Comparative Example 11 using Comparative Example 2 as a powder was also produced and evaluated. The results are shown in Table 22. The same results as in Example 14 were obtained.
<実施例16>
実施例14と同様に、下記の処方に従って、本発明の化粧料である、化粧料9〜11を作製し、同様に評価した。同様に粉体として比較例3を用いた比較例12も製造し、評価した。結果を表24に示す。実施例14と同様の結果が得られた。
<Example 16>
In the same manner as in Example 14 , cosmetics 9 to 11, which are the cosmetics of the present invention, were prepared according to the following formulation and evaluated in the same manner. Similarly, Comparative Example 12 using Comparative Example 3 as a powder was also produced and evaluated. The results are shown in Table 24. The same results as in Example 14 were obtained.
<実施例17>
実施例14と同様に、下記の処方に従って、本発明の化粧料である、化粧料12〜14を作製し、同様に評価した。同様に粉体として比較例4を用いた比較例13も製造し、評価した。結果を表26に示す。実施例14と同様の結果が得られた。
<Example 17>
In the same manner as in Example 14 , cosmetics 12 to 14, which are the cosmetics of the present invention, were prepared according to the following formulation and evaluated in the same manner. Similarly, Comparative Example 13 using Comparative Example 4 as a powder was also produced and evaluated. The results are shown in Table 26. The same results as in Example 14 were obtained.
本発明は粉末固形化粧料に応用できる。 The present invention can be applied to powder solid cosmetics.
Claims (5)
(但し、式中R 1 は水素原子又は炭素数1〜4のアルキル基を表し、R 2 は糖残基、アミノ酸残基又はホスホリルコリン残基を表し、nは0〜4の整数を表す。) 1) A composite powder in which the surface of sericite is coated with one or more metal oxides selected from silica, alumina, iron oxide, titanium dioxide, zinc oxide and zirconia. A powder for cosmetics, which is further coated with a polymer or copolymer having an acrylic acid derivative represented by formula (1) as a constituent monomer.
(In the formula, R 1 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms, R 2 represents a sugar residue, an amino acid residue or a phosphorylcholine residue, and n represents an integer of 0 to 4).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006325657A JP4859645B2 (en) | 2006-12-01 | 2006-12-01 | Powder for cosmetics and cosmetics containing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006325657A JP4859645B2 (en) | 2006-12-01 | 2006-12-01 | Powder for cosmetics and cosmetics containing the same |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2008137944A JP2008137944A (en) | 2008-06-19 |
JP2008137944A5 true JP2008137944A5 (en) | 2010-01-14 |
JP4859645B2 JP4859645B2 (en) | 2012-01-25 |
Family
ID=39599797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006325657A Active JP4859645B2 (en) | 2006-12-01 | 2006-12-01 | Powder for cosmetics and cosmetics containing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4859645B2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010037211A (en) * | 2008-07-31 | 2010-02-18 | Pola Chem Ind Inc | Solid powder cosmetic |
KR101915973B1 (en) * | 2011-10-31 | 2018-11-07 | (주)아모레퍼시픽 | Organic-inorganic composite powder for blocking UV and the cosmetic composition containing thereof |
CN103505376B (en) * | 2012-06-20 | 2019-04-30 | 株式会社爱茉莉太平洋 | For ultraviolet blocking-up organic and inorganic composite granule and contain the cosmetic composition of the composite granule |
KR101767207B1 (en) * | 2012-11-30 | 2017-08-11 | (주)아모레퍼시픽 | Inorganic powder coated by bio-compatible polymer and the cosmetic composition containing thereof |
JP7202159B2 (en) * | 2018-12-04 | 2023-01-11 | ポーラ化成工業株式会社 | Cosmetics containing powder |
JP7236349B2 (en) * | 2019-08-16 | 2023-03-09 | 信越化学工業株式会社 | Dispersible powder and cosmetics |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3178950B2 (en) * | 1993-10-19 | 2001-06-25 | ポーラ化成工業株式会社 | Powder for cosmetics and cosmetics containing the same |
JP3975880B2 (en) * | 2002-10-17 | 2007-09-12 | 日本油脂株式会社 | Cosmetics containing powder coated with surface coating |
JP2004189652A (en) * | 2002-12-10 | 2004-07-08 | Iwase Cosfa Kk | Modified powder and cosmetic |
JP4248366B2 (en) * | 2003-10-21 | 2009-04-02 | ポーラ化成工業株式会社 | Makeup for sensitive skin |
JP2006160675A (en) * | 2004-12-08 | 2006-06-22 | Pola Chem Ind Inc | Makeup cosmetic |
JP2006160703A (en) * | 2004-12-10 | 2006-06-22 | Pola Chem Ind Inc | Makeup cosmetic |
JP2006213620A (en) * | 2005-02-02 | 2006-08-17 | Fancl Corp | Water-in-oil type sun-screening cosmetic |
-
2006
- 2006-12-01 JP JP2006325657A patent/JP4859645B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5851724B2 (en) | Oil-in-water makeup cosmetics | |
JP4859645B2 (en) | Powder for cosmetics and cosmetics containing the same | |
KR101072128B1 (en) | Make up cosmetic composition of water in oil emulsion type with excellent sweat-proof | |
TW201334801A (en) | Oil-in-water-type emulsion skin cosmetic | |
JP4943128B2 (en) | Powder-containing cosmetic | |
JP2008137944A5 (en) | ||
JP4874077B2 (en) | Surface-treated powder and cosmetics containing the surface-treated powder | |
JP2008143837A5 (en) | ||
JP2008143836A5 (en) | ||
JP2010064986A (en) | Moisturizing cosmetic | |
JP4960740B2 (en) | Powder cosmetics | |
JP2010126445A (en) | Solid powder cosmetic | |
JP4880078B1 (en) | Powder cosmetics | |
JP5340588B2 (en) | Cosmetics for correcting pores | |
JP2009155211A5 (en) | ||
JP2008094756A5 (en) | ||
JP2007308381A5 (en) | ||
JP4842170B2 (en) | Solid powder cosmetics | |
JP2006008520A (en) | Moisture-retaining cosmetic | |
JP5133119B2 (en) | Cosmetic powder | |
JP4801418B2 (en) | Cosmetics for nail care | |
JP2008255030A5 (en) | ||
JP2009263249A5 (en) | ||
JP7295699B2 (en) | sunscreen cosmetics | |
JP2010001225A (en) | Skin cosmetic composition |